184 related articles for article (PubMed ID: 15137460)
1. Increased expression of TGF-beta1 in the sclerotic skin in bleomycin-'susceptible' mouse strains.
Oi M; Yamamoto T; Nishioka K
J Med Dent Sci; 2004 Mar; 51(1):7-17. PubMed ID: 15137460
[TBL] [Abstract][Full Text] [Related]
2. Animal model of sclerotic skin. III: Histopathological comparison of bleomycin-induced scleroderma in various mice strains.
Yamamoto T; Kuroda M; Nishioka K
Arch Dermatol Res; 2000 Nov; 292(11):535-41. PubMed ID: 11194891
[TBL] [Abstract][Full Text] [Related]
3. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma.
Yamamoto T; Nishioka K
Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070
[TBL] [Abstract][Full Text] [Related]
4. Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma.
Yamamoto T; Takagawa S; Katayama I; Nishioka K
Clin Immunol; 1999 Jul; 92(1):6-13. PubMed ID: 10413648
[TBL] [Abstract][Full Text] [Related]
5. UVA irradiation following treatment with topical 8-methoxypsoralen improves bleomycin-induced scleroderma in a mouse model, by reducing the collagen content and collagen gene expression levels in the skin.
Hayashi S; Ikeda M; Kitamura Y; Hamasaki Y; Hatamochi A
J Dermatol Sci; 2012 Jul; 67(1):20-5. PubMed ID: 22486844
[TBL] [Abstract][Full Text] [Related]
6. Local injection of latency-associated peptide, a linker propeptide specific for active form of transforming growth factor-beta1, inhibits dermal sclerosis in bleomycin-induced murine scleroderma.
Nakamura-Wakatsuki T; Oyama N; Yamamoto T
Exp Dermatol; 2012 Mar; 21(3):189-94. PubMed ID: 22188586
[TBL] [Abstract][Full Text] [Related]
7. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
8. Loss of beta1 integrin in mouse fibroblasts results in resistance to skin scleroderma in a mouse model.
Liu S; Kapoor M; Denton CP; Abraham DJ; Leask A
Arthritis Rheum; 2009 Sep; 60(9):2817-21. PubMed ID: 19714619
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in a mouse model of scleroderma.
Wu MH; Yokozeki H; Takagawa S; Yamamoto T; Satoh T; Kaneda Y; Katayama I; Nishioka K
Gene Ther; 2004 Jan; 11(2):170-80. PubMed ID: 14712301
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of skin sclerosis by 15deoxy delta12,14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma.
Kohno S; Endo H; Hashimoto A; Hayashi I; Murakami Y; Kitasato H; Kojima F; Kawai S; Kondo H
Biomed Pharmacother; 2006 Jan; 60(1):18-25. PubMed ID: 16337105
[TBL] [Abstract][Full Text] [Related]
11. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
[TBL] [Abstract][Full Text] [Related]
12. Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma.
Yamamoto T; Takagawa S; Katayama I; Yamazaki K; Hamazaki Y; Shinkai H; Nishioka K
J Invest Dermatol; 1999 Apr; 112(4):456-62. PubMed ID: 10201529
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-1 is elevated, but not essential, in the development of bleomycin-induced murine scleroderma.
Matsushita M; Yamamoto T; Nishioka K
Clin Exp Immunol; 2005 Mar; 139(3):429-38. PubMed ID: 15730388
[TBL] [Abstract][Full Text] [Related]
14. Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis.
Kapoor M; McCann M; Liu S; Huh K; Denton CP; Abraham DJ; Leask A
Arthritis Rheum; 2009 Sep; 60(9):2822-9. PubMed ID: 19714649
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of interleukin-13 and its receptor in a murine model of bleomycin-induced scleroderma.
Matsushita M; Yamamoto T; Nishioka K
Int Arch Allergy Immunol; 2004 Dec; 135(4):348-56. PubMed ID: 15564778
[TBL] [Abstract][Full Text] [Related]
16. Bleomycin-induced fibrosis in MC1 signalling-deficient C57BL/6J-Mc1r(e/e) mice further supports a modulating role for melanocortins in collagen synthesis of the skin.
Böhm M; Stegemann A
Exp Dermatol; 2014 Jun; 23(6):431-3. PubMed ID: 24698097
[TBL] [Abstract][Full Text] [Related]
17. Radiation-induced production of PAR-1 and TGF-beta 1 mRNA in lung of C57Bl6 and C3H murine strains and influence of pharmacoprophylaxis by ACE inhibitors.
Matej R; Housa D; Poucková P; Zadinová M; Olejár T
Pathol Res Pract; 2007; 203(2):107-14. PubMed ID: 17188433
[TBL] [Abstract][Full Text] [Related]
18. Induction of transforming growth factor beta 1 by insulin-like growth factor-1 in dermal fibroblasts.
Ghahary A; Shen Q; Shen YJ; Scott PG; Tredget EE
J Cell Physiol; 1998 Mar; 174(3):301-9. PubMed ID: 9462692
[TBL] [Abstract][Full Text] [Related]
19. Disruption of tumor necrosis factor receptor p55 impairs collagen turnover in experimentally induced sclerodermic skin fibroblasts.
Murota H; Hamasaki Y; Nakashima T; Yamamoto K; Katayama I; Matsuyama T
Arthritis Rheum; 2003 Apr; 48(4):1117-25. PubMed ID: 12687556
[TBL] [Abstract][Full Text] [Related]
20. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice.
Shen Y; Zhao HL; Du J; Li YT; Tan F; Huang CG; Pei G
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1071-7. PubMed ID: 16445573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
